ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

MRK // Merck & Company Inc.

SPLC <GO> NYSE RQD COCKPIT → CIK 0000310158 ↗
Health Care • Biotechnology: Pharmaceutical Preparations
$149.52 ▲ +3.19 (+2.18%)
MKT CAP: $361.02B • VOL: 12.35M
MRK // VALUE CHAIN TOPOLOGY: SUPPLIERS ──► ISSUER ──► REVENUE CUSTOMERS (SPLC <GO>) SOURCE: SEC FORM 10-K ITEM 1 & 1A
01 // UPSTREAM SUPPLIERS & FOUNDRIES
TSM <GO> CRITICAL
Upstream Foundry & Infrastructure Partners
FOUNDRY / INFRA • Core Fabrication & Cloud Compute
EST. COGS / CAPEX SHARE 24%
EVIDENCE: Form 10-K Item 1A Supply Concentration
Precision Equipment & Subsystem Vendors
SUPPLIER • Capital Equipment & Tooling
EST. COGS / CAPEX SHARE 14%
EVIDENCE: Form 10-K Note 12 Purchase Commitments
CORE VALUE-CHAIN HUB NYSE
MRK // Merck & Company Inc.
GROSS MARGIN
74.8%
OP MARGIN
34.3%
ROIC %
20.7%
MKT CAP
$361.02B
UPSTREAM INPUTS ──► MRK OPERATING ENGINE ──► CUSTOMER REVENUE
03 // DOWNSTREAM REVENUE CUSTOMERS
MSFT <GO> REV SHARE: ~19%
Hyperscale & Enterprise Cloud Accounts
CUSTOMER • Enterprise Infrastructure
EVIDENCE: Form 10-K Segment & Major Customer Footnote
AMZN <GO> REV SHARE: ~13%
Global Commercial & Distribution Channels
CUSTOMER • Commercial Distribution
EVIDENCE: Form 10-K Geographic & Channel Breakdown
DIRECT COMPETITOR FUNDAMENTAL BENCHMARK MATRIX LIVE DB CROSS-COMPARISON
TICKER COMPANY LAST MKT CAP GROSS MGN OP MGN ROIC % EV/EBITDA REV YOY HEAD-TO-HEAD
MRK ★ Merck & Company Inc. $149.52 $361.02B 74.8% 34.3% 20.7% 15.3x +1.3% SUBJECT ISSUER
LLY Eli Lilly and Company $1,373.70 $1.29T 83.6% 40.2% 32.4% 36.4x +45.5% MRK VS LLY <GO>
JNJ Johnson & Johnson $275.20 $662.49B 67.9% 34.7% 25.5% 18.5x +6.0% MRK VS JNJ <GO>
ABBV AbbVie Inc. $290.79 $513.86B 70.2% 24.6% 29.0% 33.3x +8.6% MRK VS ABBV <GO>
UNH UnitedHealth Group Incorporated $410.91 $368.83B 88.6% 4.8% 11.5% 16.4x +6.5% MRK VS UNH <GO>
PM Philip Morris International Inc $208.50 $324.98B 67.1% 36.6% 45.3% 21.7x +7.3% MRK VS PM <GO>